1121914

Vanderbilt Ingram Cancer Center — FEI 3016408187

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 19, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Nashville, TN (United States)

Additional Details

Clinical BA/BE